NCT07392515

Brief Summary

The aim of this study is to evaluate whether integrating a technology-based rehabilitation approach with conventional therapies in the rehabilitation of patients with proximal femoral fracture may be advantageous compared with conventional therapy alone. Specifically, the objective is to assess whether the addition of technology-assisted rehabilitation can improve cognitive function, in addition to motor function and overall abilities, compared with conventional rehabilitation alone. Furthermore, the study intends to explore the feasibility of implementing technology-assisted rehabilitation as a stable and routine component of everyday clinical practice, also considering the perspective of healthcare professionals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Feb 2026Jul 2026

First Submitted

Initial submission to the registry

January 13, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

February 9, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

March 13, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

January 13, 2026

Last Update Submit

March 11, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in serum BDNF levels

    Difference in serum brain-derived neurotrophic factor (BDNF) levels between baseline and the end of the rehabilitative treatment, assessed to evaluate biomolecular changes associated with neuroplasticity.

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Change in Timed Up and Go test

    Difference in functional mobility, balance, and gait performance assessed using the Timed Up and Go test between baseline and end of rehabilitative treatment.

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Change in Timed Up and Go Dual Task test

    Difference in cognitive-motor dual-task performance assessed using the Timed Up and Go Dual Task test between baseline and end of rehabilitative treatment.

    Baseline and within 3 days after completion of the rehabilitative treatment

Secondary Outcomes (6)

  • Change in the Harris Hip Score (HHS)

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Change in the modified Barthel Index

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Change in pain intensity measured by the Numeric Rating Scale (NRS)

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Change in quality of life measured by the SF-36

    Baseline and within 3 days after completion of the rehabilitative treatment

  • Analysis of the rs6265 polymorphism (Val66Met mutation) of the BDNF gen

    Baseline

  • +1 more secondary outcomes

Study Arms (2)

Conventional Rehabilitation

ACTIVE COMPARATOR

Patients receive a standard inpatient conventional rehabilitation program including joint mobilization, postural re-education, muscle strengthening, and gait training with assistive devices.

Other: Conventional rehabilitation intervention

Technology-Assisted Integrated Rehabilitation

EXPERIMENTAL

Patients receive an integrated rehabilitation program combining sensor-based technology-assisted training (1/3 of daily sessions) with conventional rehabilitation (2/3 of daily sessions).

Device: Experimental intervention - integrated treatment with a sensor-based device

Interventions

The conventional rehabilitation programme includes assisted and facilitated joint mobilization exercises to improve range of motion; exercises for postural readaptation of the trunk to the upright position; isometric exercises; and gait training using a 4-wheeled walker or forearm crutches (Canadian crutches), aimed at improving walking ability and achieving an appropriate recovery of the gait pattern.

Conventional Rehabilitation

The technology/robotic group will perform one-third (1/3) of the daily rehabilitation using technology-assisted devices and two-thirds (2/3) using conventional rehabilitation. In addition to the conventional rehabilitation described below, the treatment will include technology-assisted rehabilitation consisting of facilitated active joint mobilization exercises with visual and auditory feedback, aimed at stimulating motor and cognitive functions, as well as gait training.

Technology-Assisted Integrated Rehabilitation

Eligibility Criteria

Age65 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age between 65 and 89 years
  • Patients who have undergone one of the following surgical treatments specifically for proximal femur fracture including Total hip arthroplasty (total hip replacement), Partial hip arthroplasty (hemiarthroplasty), Intramedullary nailing
  • Time since surgery not exceeding 15 days
  • Clinical stability
  • Patients admitted to the rehabilitation wards of the centers involved in the study and therefore eligible for rehabilitative therapy.

You may not qualify if:

  • Age \> 90 years
  • Age \< 65 years
  • Refusal to sign the informed consent form
  • Behavioral or cognitive disorders limiting compliance with the rehabilitative treatment
  • Presence of mechanical instability of the implanted surgical device
  • Clinical instability (e.g., sepsis, severe anemia, cardiorespiratory failure) or pre-existing comorbidities affecting ambulation (neurological diseases or chronic pre-existing disabilities)
  • Concomitant presence of other fractures that prevent the possibility of carrying out a rehabilitative treatment
  • Severe visual impairments not correctable with lenses that prevent the patient from performing the treatment using digital tools
  • Pre-existing motor disability prior to the femur fracture due to other systemic diseases (e.g., advanced-stage neurodegenerative diseases, severe heart failure)
  • Conditions contraindicating the use of sensors (pacemaker, epilepsy, skin lesions, open wounds, and severe allergies in areas of contact with the devices).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

COT - Cure Ortopediche Traumatologiche

Messina, Italy, 98124, Italy

RECRUITING

Fondazione Don Carlo Gnocchi - Centro Santa Maria della Provvidenza

Roma, Italy, 00166, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Femoral Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Rehabilitation Department

Study Record Dates

First Submitted

January 13, 2026

First Posted

February 6, 2026

Study Start

February 9, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

March 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations